Search Results 191-200 of 16907 for monoclonal antibody

  1. Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    About this study. RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to ...

  2. Blistering (Bullous) Diseases Clinical Trials - Mayo Clinic Research

    Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...

  3. Tolerability, safety and deep response found in cevostamab phase 1 trial - Mayo Clinic

    Stewart and colleagues in a February 2019 issue of Blood Cancer Journal, investigators studied a naked antibody, the more commonly used type of monoclonal ...

  4. Ixekizumab in the Treatment of Bullous Pemphigoid - Mayo Clinic

    Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...

  5. Naxitamab-gqgk (intravenous route) - Mayo Clinic

    This medicine is a GD2-binding monoclonal antibody. This medicine is to be given only by or under the direct supervision of your doctor. This product is ...

  6. Telisotuzumab vedotin-tllv (intravenous route) - Side effects & uses - Mayo Clinic

    Telisotuzumab vedotin-tllv injection is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is ...

  7. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

    Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, including ...

  8. Publications - Angie N. Ton, M.D. - Mayo Clinic

    Ton A, Francis D, Speicher L. COVID-19 Patient Acceptance to Monoclonal Antibody Infusion: A Single Medical Center Experience. South Med J 2021 Aug; 114 (8): ...

  9. Claudia Manriquez Roman: CAR-T Cell Therapy for Cancer - Student Research - Mayo Clinic College of Medicine & Science

    I found similar results depleting a specific receptor involved in the apoptotic pathway. I also found tumor cells pre-treated with a monoclonal antibody, ...

  10. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety and tolerability of the combination of idelallisib with the monoclonal antibody BI ...